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1. High expression of IGSF4 in pediatric AML with MLL-rearrangements 
and t(9;11)(p22;q23)  is explained by promoter demethylation. (this 
thesis)
2. Differences in miRNA expression reflect the genetic heterogeneity of 
pediatric AML. (this thesis)
3. RUNX1 mutations occur rarely in de novo pediatric AML and seem as-
sociated with poor outcome. (this thesis)
4. Epigenetic events like miRNA deregulation and DNA methylation con-
tribute to leukemogenesis in pediatric AML, thereby providing prom-
ising candidates for future research towards targeted therapy. (this 
thesis)
5. MiR-9 is a tumor suppressor in pediatric AML characterized by t(8;21). 
(this thesis)
6. Only international collaboration will provide adequate numbers of 
pediatric AML patients to power trial questions investigating new tar-
geted therapies within subgroups. (U. Creutzig, Blood 2012)
7. The good, what particular men may do separately in relieving the sick, 
is small, compared with what they may do collectively. (B. Franklin, 
1751)
8. We need to view data as a community resource, much like a shared 
park, rather than as personal property. (J. Drazen, NEJM 2015)
9. The good physician treats the disease; the great physician treats the 
patient who has the disease. (William Osler)
10. Elke Nederlander moet vrij zijn om zijn eigen arts te kiezen. (n.a.v. aan-
passing artikel 13 zorgverzekeringswet, december 2014) 
11. It takes courage to grow up and turn out to be who you really are. (E.E. 
Cummings)
